APA (7th ed.) Citation

Chevallier, P., Labopin, M., Milpied, N., Bilger, K., Socié, G., Yakoub-Agha, I., . . . Mohty, M. (2014). Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: A survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 49(3), 361. https://doi.org/10.1038/bmt.2013.186

Chicago Style (17th ed.) Citation

Chevallier, P., et al. "Outcomes of Adults with Active or Progressive Hematological Malignancies at the Time of Allo-SCT: A Survey from the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)." Bone Marrow Transplantation 49, no. 3 (2014): 361. https://doi.org/10.1038/bmt.2013.186.

MLA (9th ed.) Citation

Chevallier, P., et al. "Outcomes of Adults with Active or Progressive Hematological Malignancies at the Time of Allo-SCT: A Survey from the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)." Bone Marrow Transplantation, vol. 49, no. 3, 2014, p. 361, https://doi.org/10.1038/bmt.2013.186.